- Home
- CLLS vs ACTG Comparison
CLLS vs ACTG Comparison
Compare CLLS & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- ACTG
- Stock Information
- Founded
- CLLS 1999
- ACTG 1993
- Country
- CLLS France
- ACTG United States
- Employees
- CLLS N/A
- ACTG N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- CLLS Health Care
- ACTG Miscellaneous
- Exchange
- CLLS Nasdaq
- ACTG Nasdaq
- Market Cap
- CLLS 299.0M
- ACTG 314.4M
- IPO Year
- CLLS 2007
- ACTG 1996
- Fundamental
- Price
- CLLS $3.22
- ACTG $3.55
- Analyst Decision
- CLLS Buy
- ACTG
- Analyst Count
- CLLS 1
- ACTG 0
- Target Price
- CLLS $8.00
- ACTG N/A
- AVG Volume (30 Days)
- CLLS 134.5K
- ACTG 195.3K
- Earning Date
- CLLS 11-07-2025
- ACTG 11-05-2025
- Dividend Yield
- CLLS N/A
- ACTG N/A
- EPS Growth
- CLLS N/A
- ACTG N/A
- EPS
- CLLS N/A
- ACTG 0.05
- Revenue
- CLLS $63,438,000.00
- ACTG $283,949,000.00
- Revenue This Year
- CLLS N/A
- ACTG $109.86
- Revenue Next Year
- CLLS $58.00
- ACTG N/A
- P/E Ratio
- CLLS N/A
- ACTG $71.03
- Revenue Growth
- CLLS 223.09
- ACTG 71.28
- 52 Week Low
- CLLS $1.10
- ACTG $2.70
- 52 Week High
- CLLS $5.48
- ACTG $4.78
- Technical
- Relative Strength Index (RSI)
- CLLS 41.41
- ACTG 54.32
- Support Level
- CLLS $3.12
- ACTG $3.24
- Resistance Level
- CLLS $3.79
- ACTG $3.72
- Average True Range (ATR)
- CLLS 0.19
- ACTG 0.15
- MACD
- CLLS -0.08
- ACTG 0.01
- Stochastic Oscillator
- CLLS 13.43
- ACTG 61.46
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.